In this educational endeavor, the goal is to enlighten learners about the prevalence of diabetes and chronic kidney disease within primary care settings. Delving into the factors that hinder or support patient involvement in their treatment, this initiative will also delve into strategies for enhancing performance and implementing activities that foster wellness in individuals with diabetes.
Novo Nordisk has announced the permanent discontinuation of all formulations of Levemir. Supply disruptions of Levemir FlexPen are expected to begin in mid-January 2024, followed by the complete discontinuation of the FlexPen on April 1, 2024. The Levemir vial will be discontinued on December 31, 2024.
According to the American Diabetes Association, more than 60,000 people in North Carolina are diagnosed with Diabetes every year.
No Cost to Attend - Live Webinars in August. This series of three interactive webinars for the practice team addresses different aspects of primary care management of patients with diabetes.
Register now for the diabetes self-management presentation on May 11 and adolescent immunization on May 16.
You are invited to participate in Medicaid Quality Improvement Work with NC AHEC — your gateway to Population Health Improvement and Shared Savings!
You’re Invited to Participate in Medicaid Quality Improvement Work with NC AHEC — your gateway to Population Health Improvement and Shared Savings!
